Merck, Glenmark must face trimmed US antitrust case over Zetia, judge rules
MLex Summary: Merck and Glenmark Pharmaceuticals must face Humana’s US claims for damages over purchases of the Merck drug Vytorin in a pay-for-delay suit over generic Zetia, a federal judge ruled....To view the full article, register now.
Already a subscriber? Click here to view full article